Irving Investors
Irving Investors is a growth-oriented, sector-agnostic crossover investment firm founded in 2009 by Jeremy Abelson. The firm runs a single-name strategy combining a predominantly long-only public equities book with an active late-stage venture portfolio, frequently taking board seats. Headquartered in Denver, Colorado with an additional office in New York, Irving has backed technology and healthcare companies including unicorns Snyk and Rebel Foods, and has seen multiple IPO and acquisition exits, most recently Cybereason (acquired by LevelBlue, October 2025).
New York, United States · 6+ investments · 5 portfolio companies
- Headquarters
- New York, United States
- Founded
- 2009
- Website
- irvinginvestors.com
- Portfolio Companies
- 5
- Total Investments
- 6
- Last Investment
- Nov 2021
- Geographic Focus
- United States
Investment Thesis
Irving Investors is a Venture Capital firm based in New York, United States. It has made 6 investments, including Genomatica, Model Medicines and Crossover Health. Focus areas include Healthcare.
Portfolio5
Co-investors24
Sign up to view co-investors
24 co-investors across 24 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×16 · Hedge Fund ×3 · Private Equity ×2 · 23 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/irving-investors"><img src="https://indexed.vc/api/badge/investor/irving-investors" alt="Irving Investors on Indexed.vc" width="260" height="76" /></a>